- Home
- RLMD vs TWIN Comparison
RLMD vs TWIN Comparison
Compare RLMD & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLMD | TWIN |
|---|---|---|
| Founded | 2004 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.7M | 269.7M |
| IPO Year | 2012 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RLMD | TWIN |
|---|---|---|
| Price | $7.19 | $16.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $10.25 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 542.6K | 54.2K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | ★ 19.21 | N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | $13,070.00 | ★ $340,738,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $11.35 |
| Revenue Growth | ★ 154.83 | 15.45 |
| 52 Week Low | $0.24 | $6.16 |
| 52 Week High | $5.12 | $19.63 |
Technical Indicators
Market Signals| Indicator | RLMD | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 79.95 | 44.96 |
| Support Level | $3.65 | $16.46 |
| Resistance Level | N/A | $19.22 |
| Average True Range (ATR) | 0.47 | 0.90 |
| MACD | 0.20 | -0.07 |
| Stochastic Oscillator | 98.67 | 14.91 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.